Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00695279
What this trial is testing

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

Who this might be right for
Severe Combined ImmunodeficiencyMalignancy, HematologicNeuroblastoma+2 more
St. Jude Children's Research Hospital 41
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Not applicableStudy completedNCT06371573
What this trial is testing

Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative NeoplasmPolycythemia VeraEssential Thrombocythemia+2 more
Federico II University 45
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT05873205
What this trial is testing

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Ended earlyNCT04614636
What this trial is testing

FT538 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAML, AdultMultiple Myeloma+1 more
Fate Therapeutics 42
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Early research (Phase 1)Active Not RecruitingNCT04623944
What this trial is testing

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

Who this might be right for
Relapsed/Refractory AMLAML, AdultMDS+1 more
Nkarta, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT01660607
What this trial is testing

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Who this might be right for
Myeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more
Stanford University 68
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Ended earlyNCT02418000
What this trial is testing

E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations

Who this might be right for
AMLMDSCMML
Spirita Oncology, LLC 27
Testing effectiveness (Phase 2)Study completedNCT00943592
What this trial is testing

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

Who this might be right for
Advanced Hematologic MalignanciesLeukemiaPreleukemia
University of Chicago 82
Not applicableLooking for participantsNCT01772771
What this trial is testing

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center 12,000
Early research (Phase 1)Looking for participantsNCT07012109
What this trial is testing

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Who this might be right for
Polycythemia Vera
BeBetter Med Inc 90
Early research (Phase 1)Ended earlyNCT01991938
What this trial is testing

Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

Who this might be right for
Non Hematologic CancersMetastatic CancerLymphoma
Verastem, Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT07007052
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
French Innovative Leukemia Organisation 33
Not applicableStudy completedNCT06267417
What this trial is testing

Laser Therapy Effect as Preventive Measure for Oral Mucositis in Children With Hematological Malignancies

Who this might be right for
Oral Mucositis
Children's Cancer Hospital Egypt 57357 42
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Post-approval studies (Phase 4)Study completedNCT07793838
What this trial is testing

Metformin Effects on Metabolic, Vitamin B12, Iron, Erythropoietin, and Hematological Parameters in Women With PCOS

Who this might be right for
Polycystic Ovary Syndrome (PCOS) Women
Jerash Private University 400
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Next Page